Chronic Radiation Dermatitis (Investigational)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for chronic radiation dermatitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

What evidence exists?

Tier C (investigational). No controlled trials. Evidence-based first-line management of chronic radiation dermatitis is meticulous skin care with bland emollients, topical corticosteroid for inflammatory flares, photoprotection, treatment of secondary infection, and for severe cases hyperbaric oxygen therapy or surgical excision and reconstruction of fibrotic non-healing wounds.

Main risks

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Bleeding from already-friable irradiated tissue that does not heal normally
• Wound dehiscence or chronic non-healing bite ulcer in irradiated skin
• Aeromonas or other infection in tissue with poor immune defense

Who should not consider this

• Patients with active malignancy in the radiated field (need oncology assessment first)
• Patients with non-healing or ulcerated radiated skin (any new wound may not heal)
• Patients who have not tried hyperbaric oxygen if indicated
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)
• People with an active infection at the planned application site

What to ask your clinician

• Has my oncologist confirmed no recurrent malignancy in the treatment area?
• Has hyperbaric oxygen therapy been considered or tried?
• What is the wound-healing risk in my irradiated skin (it may not heal a leech bite)?
• What is the bleeding-control plan in friable tissue?
• What is the published evidence base for leeches in radiation dermatitis?
• What is the plan if a bite site does not heal?

When to seek urgent care

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Non-healing bite site after 4 weeks (radiated tissue may not heal)
• New lump, mass, or ulcer in the radiated field (must exclude radiation-induced malignancy)